Literature DB >> 6402229

Treatment of bacterial meningitis.

H P Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6402229      PMCID： PMC1547024          DOI： 10.1136/bmj.286.6367.741

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  19 in total

1.  Meningitis due to chloramphenicol-resistant Haemophilus influenzae type b.

Authors:  A L Kinmonth; C N Storrs; R G Mitchell
Journal:  Br Med J       Date:  1978-03-18

2.  A pharmacologic evaluation of penicillin in children with purulent meningitis.

Authors:  J P Hieber; J D Nelson
Journal:  N Engl J Med       Date:  1977-08-25       Impact factor: 91.245

3.  Haemophilus influenzae type B resistant to ampicillin and chloramphenicol in an orphanage in Thailand.

Authors:  S Simasathien; C Duangmani; P Echeverria
Journal:  Lancet       Date:  1980-12-06       Impact factor: 79.321

4.  Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol.

Authors:  N Uchiyama; G R Greene; D B Kitts; L D Thrupp
Journal:  J Pediatr       Date:  1980-09       Impact factor: 4.406

5.  The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges.

Authors:  C Müller; A Netland; A F Dawson; E Andrew
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

6.  Cephalothin and cephaloridine therapy for bacterial meningitis.

Authors:  L S Fisher; A W Chow; T T Yoshikawa; L B Guze
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

7.  Intravenous cefotaxime in children with bacterial meningitis.

Authors:  B H Belohradsky; K Bruch; D Geiss; D Kafetzis; W Marget; G Peters
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

8.  Streptococcus pneumoniae resistant to penicillin and chloramphenicol.

Authors:  P C Appelbaum; A Bhamjee; J N Scragg; A F Hallett; A J Bowen; R C Cooper
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321

9.  Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.

Authors:  S L Kaplan; E O Mason; H Garcia; S J Kvernland; E M Loiselle; D C Anderson; A A Mintz; R D Feigin
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

10.  Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.

Authors:  U B Schaad; G H McCracken; N Threlkeld; M L Thomas
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.